Submitted by Anonymous (not verified) on 11 November 2025 - 12:00
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 9, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 9, Status: Authorised